Congress Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.87M Sell
94,779
-2,483
-3% -$208K 0.08% 295
2025
Q1
$8.16M Sell
97,262
-16,826
-15% -$1.57M 0.1% 241
2024
Q4
$10.5M Buy
114,088
+4,279
+4% +$411K 0.14% 192
2024
Q3
$10.2M Buy
109,809
+4,932
+5% +$427K 0.14% 207
2024
Q2
$8.63M Buy
104,877
+5,891
+6% +$433K 0.14% 192
2024
Q1
$6.57M Buy
98,986
+21,532
+28% +$1.33M 0.11% 202
2023
Q4
$4.4M Sell
77,454
-1,080
-1% -$56.6K 0.08% 235
2023
Q3
$4.28M Buy
78,534
+3,812
+5% +$226K 0.09% 231
2023
Q2
$5.03M Buy
74,722
+63,078
+542% +$3.85M 0.12% 190
2023
Q1
$599K Buy
11,644
+11
+0.1% +$534 0.01% 394
2022
Q4
$535K Sell
11,633
-2,919
-20% -$137K 0.01% 397
2022
Q3
$737K Buy
14,552
+108
+0.7% +$5.4K 0.02% 363
2022
Q2
$658K Buy
14,444
+1,551
+12% +$69.4K 0.02% 374
2022
Q1
$599K Buy
12,893
+2,319
+22% +$104K 0.01% 420
2021
Q4
$531K Buy
+10,574
New +$547K 0.01% 457

Other funds holding LMAT